Predictions
Austria Microsystems AG
Start price
Target price
Perf. (%)
€20.30
22.02.21
22.02.21
€30.00
-9.85%
06.03.21
06.03.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Pfeiffer Vacuum
Start price
Target price
Perf. (%)
€168.60
22.02.21
22.02.21
€180.00
-7.12%
06.03.21
06.03.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
SSR Mining Inc. CDIS
Start price
Target price
Perf. (%)
€12.20
22.02.21
22.02.21
€18.00
22.02.22
22.02.22
27.05%
22.02.22
22.02.22
Xiaomi Corp.
Start price
Target price
Perf. (%)
€3.11
21.02.21
21.02.21
-
21.02.22
21.02.22
-43.63%
22.02.22
22.02.22
Innovative
Future proof or reliable business model
Differentiated customer and product portfolio
Higher risks for its business
Teleflex Inc.
Start price
Target price
Perf. (%)
€320.00
21.02.21
21.02.21
-
21.02.22
21.02.22
14.38%
23.04.21
23.04.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Gamestop Corp.
Start price
Target price
Perf. (%)
€9.02
21.02.21
21.02.21
€10.75
274.01%
25.02.21
25.02.21
Could be very worthwhile Investment >20% year
Aap Implantate AG
Start price
Target price
Perf. (%)
€3.31
21.02.21
21.02.21
€4.00
21.02.22
21.02.22
-4.39%
22.02.22
22.02.22
Top 10 in its market
Revenue growth >5% per year expected
Future proof or reliable business model
Higher EBIT margin than peer group
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Vita 34 AG
Start price
Target price
Perf. (%)
€15.55
21.02.21
21.02.21
-
21.02.22
21.02.22
-25.08%
22.02.22
22.02.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Sfc Energy AG
Start price
Target price
Perf. (%)
€31.95
21.02.21
21.02.21
€29.00
21.02.22
21.02.22
-39.22%
22.02.22
22.02.22
Small challenges to pay loans and raise capital
Capable Management
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Xiaomi Corp.
Start price
Target price
Perf. (%)
€3.11
21.02.21
21.02.21
€5.00
21.02.22
21.02.22
-43.63%
22.02.22
22.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
Nanogate AG
Start price
Target price
Perf. (%)
€1.21
21.02.21
21.02.21
€0.000
21.02.22
21.02.22
-94.24%
22.02.22
22.02.22
Probably not worthwhile Investment
Below average Marketposition
Significant cyclical dependencies
Business model of the past or high risk
Microsoft Corp.
Start price
Target price
Perf. (%)
€198.38
21.02.21
21.02.21
€220.00
21.02.22
21.02.22
28.54%
21.02.22
21.02.22
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.22
21.02.21
21.02.21
-
21.02.22
21.02.22
-5.21%
06.03.21
06.03.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
NVIDIA Corp.
Start price
Target price
Perf. (%)
€3.07
21.02.21
21.02.21
€3.19
21.02.22
21.02.22
62.79%
22.02.22
22.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very small cyclical dependencies
Known brand
Ocean Power Technologies Inc.
Start price
Target price
Perf. (%)
€3.72
21.02.21
21.02.21
€2.00
21.02.22
21.02.22
-75.36%
22.02.22
22.02.22
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Neonode Inc.
Start price
Target price
Perf. (%)
€7.55
21.02.21
21.02.21
€9.00
21.02.22
21.02.22
-42.52%
22.02.22
22.02.22
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Global Fashion Group SA
Start price
Target price
Perf. (%)
€14.99
21.02.21
21.02.21
-
21.02.22
21.02.22
-21.44%
04.03.21
04.03.21
Probably not worthwhile Investment
Newmont Mining Corp._INT
Start price
Target price
Perf. (%)
€47.33
20.02.21
20.02.21
-
20.02.22
20.02.22
27.02%
26.05.21
26.05.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Future proof or reliable business model
Higher risks for its business
Inovio Pharma
Start price
Target price
Perf. (%)
€11.30
20.02.21
20.02.21
€6.80
20.02.22
20.02.22
-38.75%
10.07.21
10.07.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€23.36
20.02.21
20.02.21
€26.40
20.02.22
20.02.22
-34.73%
06.05.21
06.05.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year